DEBORAH J. ANDREWS

Insider Reports History

Location
Monrovia, CA
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Deborah Andrews
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DEBORAH J. ANDREWS:

Company Role Class Num Shares Value Price $ Report Date Ownership
STAAR SURGICAL CO Interim Co-CEO and CFO Common Stock 8,586 $154,548 $18.00 17 Mar 2025 Direct
Lineage Cell Therapeutics, Inc. Director Stock Option (Right to Buy) 75,000 01 Jul 2025 Direct
STAAR SURGICAL CO Interim Co-CEO and CFO Restricted Stock Units 20,787 02 Feb 2026 Direct

Insider Reports Filed by DEBORAH J. ANDREWS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STAA STAAR SURGICAL CO 02 Feb 2026 1 $0 4 Interim Co-CEO and CFO 04 Feb 2026, 17:28
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2025 1 $0 4 Director 02 Jul 2025, 21:00
STAA STAAR SURGICAL CO 25 Jun 2025 1 $0 4 CFO 26 Jun 2025, 18:31
STAA STAAR SURGICAL CO 17 Mar 2025 0 $0 3 Interim CFO 18 Mar 2025, 18:02
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2024 1 $0 4 Director 03 Jul 2024, 17:00
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2023 1 $0 4 Director 03 Jul 2023, 17:46
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2022 1 $0 4 Director 06 Jul 2022, 16:15
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2021 1 $0 4 Director 01 Jul 2021, 18:29
LCTX Lineage Cell Therapeutics, Inc. 29 Jun 2021 3 -$1,702 4 Director 30 Jun 2021, 19:01